United States · United States Congress · 18 March 2025
Preserving Patient Access to Home Infusion Act This bill specifically includes pharmacy services and home infusion drugs that are administered without a pump as part of covered home infusion therapy under Medicare. The bill also allows nurses and physician assistants to establish and review the plan of care for home infusion therapy, and it specifies that payment may be made regardless of whether a practitioner is physically present in the home at the time the drug is administered.
United States · United States Congress · 14 March 2025
Reimbursing Border Communities Act of 2025 This bill requires the Department of Homeland Security to make grants to certain border communities for expenses related to security measures along the southern border. Specifically, the local government of a community is eligible for a grant if it is located within 200 miles of the border and is not a sanctuary jurisdiction as defined by the bill. Additionally, no grant may be used to reimburse nonprofit organizations, fund legal representation, or provide educational, housing, food, or health care resources to a non-U.S. national ( alien under federal law).
United States · United States Congress · 14 March 2025
Safe Vehicle Access for Survivors Act This bill requires providers of connected vehicle services, upon the request of a domestic violence survivor, to terminate or disable an identified domestic abuser’s access to a vehicle’s connected capabilities and data. Specifically, within two business days of receiving a request from a survivor, a covered provider must, if technically feasible (1) terminate or disable the connected vehicle account associated with the identified abuser or the relevant vehicle, or the vehicle’s connected capabilities; or (2) instruct the survivor on how to terminate or disable connected services directly. Covered providers may not make the termination of connected vehicle services or accounts contingent on any requirement other than the provision of specified information by the survivor. For example, a provider may not require a survivor to pay a fee or extend their contract with the provider. Under the bill, an abuser is an individual identified by a survivor who committed or allegedly committed certain acts against the survivor, including domestic violence, sexual assault, stalking, and sex trafficking. A survivor is an adult against whom such an act was committed. Further, a covered provider is a vehicle manufacturer, affiliate, or entity acting on behalf of a manufacturer that provides a connected vehicle service. Connected vehicle service is any capability that enables a person to remotely access data from or send commands to a vehicle. Finally, the Federal Communications Commission must prescribe regulations governing how covered providers address survivors’ requests related to connected vehicles.
United States · United States Congress · 14 March 2025
Radiation Oncology Case Rate Value Based Program Act of 2025 or the ROCR Value Based Program Act This bill establishes a specialized payment program under Medicare for providers and suppliers of radiation oncology services. Specifically, the Centers for Medicare & Medicaid Services (CMS) must establish a program under which radiation therapy providers (i.e., hospital outpatient departments) and suppliers (i.e., physician group practices and freestanding radiation therapy centers) receive payments for each episode of care provided to individuals with specified types of cancer. An episode of care means the period beginning on the day radiation therapy planning is furnished to the individual and ending (1) for individuals with bone or brain metastases, 30 days later; and (2) for individuals with other cancer types, 90 days later. Participation in the program is mandatory for providers and suppliers that participate in Medicare, unless the provider or supplier is part of a state-based Center for Medicare & Medicaid Innovation model or qualifies for a significant hardship exemption. The CMS must set payment rates for the program based on national payment rates with specified adjustments (e.g., geographic adjustments). Providers and suppliers who provide certain transportation services for individuals under their care may receive an additional payment. Providers and suppliers must be accredited in accordance with certain standards, subject to payment reductions. The Government Accountability Office must report on (1) implementation of the program, and (2) underserved areas that are in need of more or newer radiation therapy resources.
United States · United States Congress · 14 March 2025
Fair and Open Competition Act of 2025 or the FOCA Act of 2025 This bill requires that federal contracts for construction projects neither require nor prohibit a bidder, offeror, contractor, or subcontractor from entering into agreements with one or more labor organizations with respect to such projects or related projects. Under the bill, the controlling documents for federal construction contracts (such as bid specifications and project agreements) may not require or prohibit a bidder, offeror, contractor, or subcontractor from entering into or adhering to such labor agreements. Additionally, the controlling documents may not discriminate against or give preference to a bidder, offeror, contractor, or subcontractor who signs or refuses to sign such a labor agreement. These requirements also apply to any (1) construction manager acting on behalf of the federal government with respect to such contract, (2) recipient of a federal grant or financial assistance for construction projects or construction manager acting on the recipient's behalf, and (3) party to a federal cooperative agreement for construction projects or construction managers acting on the party's behalf. An agency may exempt a project from this prohibition to avert an imminent threat to public health or safety or to serve the national security.
United States · United States Congress · 11 March 2025
Traveler's Gun Rights Act This bill broadens the scope of allowable firearms transactions involving active duty servicemembers and their spouses and individuals who do not have a residence in any state. Currently, federal firearms laws generally prohibit a federal firearms licensee (e.g., a gun dealer) from selling or delivering a firearm to an individual whose state of residence is different than the state where the licensee's place of business is located. This bill defines the term state of residence as the state in which an individual is present with an intention of making a home. In the case of an individual who does not have a physical residence in any state, the term state of residence means the address of the individual's private mailbox or post office box. In the case of a member of the Armed Forces on active duty, or his or her spouse, the term state of residence means (1) the state in which the member's permanent duty station is located, and (2) the state where the member maintains a place of abode from which he or she commutes to the permanent duty station.
United States · United States Congress · 10 March 2025
25th Anniversary of 9/11 Commemorative Coin Act This bill directs the Department of the Treasury to mint and issue coins to commemorate the 25th anniversary of the September 11, 2001, terrorist attacks on the United States and the establishment of the National September 11 Memorial and Museum at the World Trade Center. The sale of all coins issued under this bill must include a surcharge to be paid to the National September 11 Memorial and Museum at the World Trade Center to support operations and maintenance. However, if the issuance of this commemorative coin exceeds certain annual limits, no surcharge may be included.
United States · United States Congress · 10 March 2025
This joint resolution nullifies the final rule issued by the Department of Energy's Office of Energy Efficiency and Renewable Energy titled Energy Conservation Program: Energy Conservation Standards for Commercial Refrigerators, Freezers, and Refrigerator-Freezers and published on January 21, 2025. Under the rule, the office adopted new and amended energy conservation standards for commercial refrigeration equipment in order to achieve the maximum improvement in energy efficiency that is technologically feasible and economically justified.
United States · United States Congress · 10 March 2025
This bill designates the facility of the United States Postal Service located at 620 East Pecan Boulevard in McAllen, Texas, as the "Agent Raul H. Gonzalez Jr. Memorial Post Office Building".
United States · United States Congress · 6 March 2025
Pay Our Border Patrol and Customs Agents Act of 2025 This bill provides FY2025 appropriations for the salaries and expenses of certain U.S. Customs and Border Protection (CBP) employees who are required to work during a lapse in appropriations (i.e., government shutdown) in FY2025. Specifically, the bill provides appropriations to CBP for the salaries and expenses of agents of the U.S. Border Patrol and officers of the Office of Field Operations who are excepted from furlough (i.e., required to work) during a lapse in discretionary appropriations in FY2025.
United States · United States Congress · 6 March 2025
Access to Pediatric Technologies Act of 2025 This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish, upon request, specific payment methodologies for qualifying pediatric technologies under the Medicare physician fee schedule. Qualifying pediatric technologies are medical devices that are (1) covered under Medicare, (2) approved by the Food and Drug Administration, (3) currently billed using a specified temporary billing code for emerging technologies, and (4) predominantly used or specifically designated for pediatric patients. The CMS must develop a payment methodology for a qualifying pediatric technology upon request from the manufacturer and based on available data, including pricing information and claims data. Manufacturers must include relevant information in their requests to enable the CMS to develop the corresponding methodologies.
United States · United States Congress · 6 March 2025
Unlocking our Domestic LNG Potential Act of 2025 This bill repeals certain restrictions on the import and export of natural gas under the Natural Gas Act, including requirements for Department of Energy (DOE) approval and related provisions that address free trade agreements. In addition, the bill grants the Federal Energy Regulatory Commission (FERC) the exclusive authority to approve or deny applications to authorize the siting, construction, expansion, or operation of facilities (e.g., liquefied natural gas terminals) to export natural gas to foreign countries or import natural gas from foreign countries. (Currently, DOE authorizes the export or import of natural gas, and FERC authorizes related facilities.) In determining whether to approve or deny an application, FERC must deem the exportation or importation of natural gas to be consistent with the public interest.
United States · United States Congress · 6 March 2025
Anti-CBDC Surveillance State Act This bill prohibits a Federal Reserve bank from offering products or services directly to an individual, maintaining an account on behalf of an individual, or issuing a central bank digital currency (i.e., a digital dollar). Further, the Board of Governors of the Federal Reserve System is prohibited from using a central bank digital currency to implement monetary policy or from testing, studying, creating, or implementing a central bank digital currency, with exceptions as provided by the bill.
United States · United States Congress · 6 March 2025
This bill authorizes the U.S. Section of the International Boundary and Water Commission, United States and Mexico (USIBWC) to accept funds to study, design, construct, operate, or maintain wastewater treatment works, water conservation projects, or flood control works, and related structures. The USIBWC is a federal government agency and the U.S. component of the International Boundary and Water Commission, which applies the boundary and water treaties of the United States and Mexico and settles differences that may arise in their application. The USIBWC may not provide credit towards the nonfederal share of project costs, or reimbursement, to nonfederal entities in an amount that exceeds $5 million in any fiscal year. Further, the USIBWC may not accept funds from any nonfederal entity that (1) is domiciled in, headquartered in, or organized under the laws of a foreign country of concern (e.g., China, North Korea, Russia, or Iran); or (2) has in place any agreement with a foreign country of concern. Any funds accepted by the USIBWC must be deposited into the account titled International Boundary and Water Commission, United States and Mexico .
United States · United States Congress · 5 March 2025
Streamlining Program Efficiency and Expanding Deployment for BEAD Act or the SPEED for BEAD Act This bill makes certain changes to the Broadband, Equity, Access, and Deployment (BEAD) Program, including by expanding the broadband technologies that may qualify for funding and prohibiting states from regulating broadband rates in connection with the program. (The BEAD Program is administered by the National Telecommunications and Information Administration (NTIA) and provides funding to eligible entities for broadband deployment, connectivity, mapping, and adoption projects. Eligible entities include U.S. states, territories, and the District of Columbia.) Specifically, the bill establishes that projects using any broadband technology (e.g., satellite, fixed wireless, or fiber) may qualify for funding, provided the technology meets specified performance criteria. (Original BEAD rules established a preference for fiber projects.) The bill also explicitly prohibits eligible entities from regulating, setting, or otherwise mandating pursuant to the BEAD Program (1) rates charged for broadband service, or (2) methodologies used to calculate such rates. The prohibition includes rate regulation carried out in conjunction with the existing requirement that subgrantees offer at least one low-cost broadband service option to certain subscribers. Further, the bill prohibits the NTIA and eligible entities from establishing or enforcing conditions, preferences, or other requirements related to collective bargaining and labor agreements; climate change; diversity, equity, and inclusion; and other topics. The bill also modifies the purposes for which the funds may be used and the treatment of unused funds. Finally, the bill replaces the term Equity in the program’s name with Expansion .
United States · United States Congress · 5 March 2025
Continuing Robust and Uninhibited Drilling and Exporting Act or the CRUDE Act This bill limits the President's authority to restrict the export of crude oil from the United States. Currently, the President may restrict the export of oil for up to a year if the President declares a national emergency; the restrictions are sanctions or trade restrictions that apply to countries, persons, or organizations for national security reasons; or the Department of Commerce, in consultation with the Department of Energy (DOE), finds and reports to the President that the export of U.S. crude oil has caused sustained material oil supply shortages or sustained oil prices significantly above world market levels that have caused or are likely to cause sustained material adverse employment effects. However, this bill only allows the President to impose such restrictions if the President declares a national emergency based on findings that are jointly issued by Department of Defense, DOE, and Commerce and include the conclusions described above about oil supply shortages or increased oil prices; or the restrictions are sanctions or trade restrictions that apply to countries, persons, or organization for national security reasons.
United States · United States Congress · 3 March 2025
Federal Firearms Licensee Protection Act of 2025 This bill modifies criminal penalties for an offense involving the theft of a firearm from a licensed importer, manufacturer, or dealer, or from their business premises. Specifically, the bill does the following: increases from 10 to 20 years the maximum prison term, and creates a 3- or 5-year mandatory minimum prison term for an offense that occurs during the commission of a burglary or robbery. An attempt to commit an offense is subject to the same penalties as a substantive offense.
United States · United States Congress · 27 February 2025
Maintaining Investments in New Innovation Act This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)
United States · United States Congress · 25 February 2025
This joint resolution nullifies the Environmental Protection Agency rule titled National Emission Standards for Hazardous Air Pollutants: Rubber Tire Manufacturing (89 Fed. Reg. 94886) and published on November 29, 2024. The rule addresses the decision in Louisiana Environmental Action Network v. EPA (D.C. Cir. 2020) by implementing emissions standards for the rubber processing subcategory of the rubber tire manufacturing industry to ensure all emissions of hazardous air pollutants from sources in the source category are regulated.
United States · United States Congress · 24 February 2025
New Era of Preventing End-Stage Kidney Disease Act This bill establishes regional centers of excellence, postgraduate fellowships, and training for health professionals relating to the diagnosis and treatment of rare kidney disease. It also requires the Department of Health and Human Services (HHS) to conduct various studies on rare kidney disease. Specifically, it authorizes the National Institute of Diabetes and Digestive and Kidney Diseases to award funding to public and private nonprofit entities for establishing regional centers of excellence that will increase public awareness, conduct research, and develop resources for diagnosing and treating rare kidney diseases. A center may receive such funding for up to five years, unless extended by the institute. The bill also requires health professions schools receiving a grant from the Health Resources and Services Administration (HRSA) Centers of Excellence program to award fellowships for training on preventing, diagnosing, and treating rare kidney disease in disproportionately impacted populations. Also, the bill expands the priorities of HRSA’s Primary Care Training and Enhancement program to include training for health care workers to care for individuals with kidney disease. Additionally, HHS must conduct several studies and report to Congress on topics such as treating rare kidney disease in disproportionately affected populations, eliminating the need for dialysis or kidney transplants, and increasing public awareness of rare kidney disease.
United States · United States Congress · 24 February 2025
Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be program-certified in order to dispense mifepristone. The modifications allow certified retail pharmacies to dispense mifepristone pursuant to prescriptions that are written by certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.
United States · United States Congress · 24 February 2025
Medical Device Electronic Labeling Act This bill expands the permitted use of electronic labeling of medical devices to allow directions for use and warning labels for all medical devices to be provided electronically, rather than physically (i.e., affixed to or accompanying the device or its container). (Under current law, direction and warning labels may be provided electronically only for (1) prescription devices intended for use in health care facilities or by health care professionals, and (2) in vitro diagnostic devices intended for use in blood establishments or by health care professionals.) Under the bill, direction and warning labels may be provided solely electronically for all medical devices so long as (1) the electronic label is readily accessible to the device’s intended users, (2) intended users may request a paper label at no additional cost, and (3) the label affixed to the device or its packaging contains all information required under current laws and regulations. The Food and Drug Administration may issue regulations establishing additional requirements or exceptions to these provisions.
United States · United States Congress · 21 February 2025
This bill lengthens the amount of time for which drug products must have market approval in order for the products to qualify for negotiation under the Medicare Drug Price Negotiation Program. The Medicare Drug Price Negotiation Program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation. The bill modifies these provisions so as to require drug products to also have had at least 11 years of market approval in order to qualify for negotiation. The bill's changes apply retroactively.
United States · United States Congress · 21 February 2025
This bill reauthorizes from FY2026-FY2030 and expands Department of Health and Human Services (HHS) programs relating to traumatic brain injuries. It also requires HHS to conduct a study and report to Congress on traumatic brain injuries. Specifically, the bill reauthorizes Centers for Disease Control and Prevention (CDC) grants to states for traumatic brain injury surveillance and registries (renaming the program after the late Representative Bill Pascrell, Jr.), CDC research and public awareness activities to reduce traumatic brain injuries, Administration for Community Living (ACL) grants to states and American Indian consortiums for services and support for individuals living with traumatic brain injuries, and ACL grants for protection and advocacy agencies supporting individuals with traumatic brain injuries. Also, the bill generally expands the scope and requirements of these programs, including by requiring the CDC to publish information on populations at higher risk for traumatic brain injuries and strategies for preventing such injuries in these populations. Additionally, HHS must conduct a study on long-term symptoms or conditions in people who experience traumatic brain injuries and report the findings to Congress. HHS must also submit a report to Congress on populations with a higher risk of traumatic brain injuries and outreach efforts for such populations.
United States · United States Congress · 21 February 2025
Accelerating Kids’ Access to Care Act of 2025 This bill requires states to establish a process through which qualifying out-of-state providers may temporarily treat children under Medicaid and the Children's Health Insurance Program (CHIP) without undergoing additional screening requirements. Specifically, states must establish a process through which qualifying out-of-state providers may enroll for five years as participating providers to treat individuals under the age of 21 without undergoing additional screening requirements. A qualifying out-of-state provider (1) must not have been excluded or terminated from participating in a federal health care program or state Medicaid program; and (2) must have been successfully enrolled in Medicare or a state Medicaid program based on a determination that the provider posed a limited risk of fraud, waste, or abuse. The bill’s changes take effect three years after enactment.
United States · United States Congress · 21 February 2025
This bill prohibits the use of federal funds to implement, administer, or enforce the final rule issued by the Food and Drug Administration (FDA) titled Medical Devices; Laboratory Developed Tests and published on May 6, 2024, or any substantially similar rule. The rule specifies that laboratory developed tests (medical screening tests developed by laboratories rather than medical device manufacturers) are medical devices subject to FDA regulation with limited exceptions. Prior to the rule, the FDA had exercised discretion as to whether to apply regulations for medical devices to laboratory developed tests.
United States · United States Congress · 18 February 2025
Increasing Access to Dental Insurance Act This bill permits individuals to enroll in a dental benefits plan on a health insurance exchange without also enrolling in a qualified health plan.
United States · United States Congress · 18 February 2025
Enhanced Iran Sanctions Act of 2025 This bill imposes sanctions on certain foreign persons (individuals and entities) that are involved in Iran's petroleum sector as well as certain associated persons. The bill also requires or authorizes actions to facilitate the enforcement of sanctions on Iran. Specifically, the bill requires the President to impose visa- and property-blocking sanctions on any foreign person that, after the bill's enactment, knowingly engages in any transaction related to the processing, export, or sale of oil, condensates, gas, liquefied natural gas, or other petrochemical products in whole or in part from Iran. The President must also impose sanctions on certain foreign persons associated with a sanctioned individual or entity. For example, the President must sanction the subsidiaries and corporate officers of a sanctioned business. The bill provides certain exceptions to these sanctions, including specifying that sanctions do not apply to the importation of goods or to conducting or facilitating transactions for humanitarian assistance. The Department of State must establish an interagency working group that shall seek to establish a multilateral contact group to coordinate international efforts to enforce sanctions on Iran. The bill expands the State Department rewards program to authorize a reward payment to any individual who furnishes information leading to the identification of a person (1) subject to sanctions under this bill, or (2) that has attempted or is attempting to evade sanctions under this bill.
United States · United States Congress · 14 February 2025
Automotive Support Services to Improve Safe Transportation Act of 2025 or the ASSIST Act of 2025 This bill expands the definition of medical services for purposes of veterans’ benefits to include additional medically necessary automobile adaptations. Under the bill, the Department of Veterans Affairs may provide funding for ramp and kneeling systems, lowered floors, mobility device lifts, non-articulating trailers, and ingress or egress accessibility modifications.
United States · United States Congress · 13 February 2025
Driver Reimbursement Increase for Veteran Equity Act of 2025 or the DRIVE Act of 2025 This bill increases the mileage reimbursement rate available to beneficiaries for travel to or from Department of Veterans Affairs (VA) facilities in connection with vocational rehabilitation, required counseling, or for the purpose of examination, treatment, or care. Specifically, the bill makes the reimbursement rate for such travel equal to or greater than the mileage reimbursement rate for government employees using private vehicles when no government vehicle is available. The bill also requires the VA to ensure that an allowance based on mileage is paid not later than 90 days after the request is properly submitted to the VA.
United States · United States Congress · 13 February 2025
This concurrent resolution declares that Congress should not impose any new performance fee, tax, royalty, or other charge relating to the public performance of sound recordings on a local radio station for broadcasting sound recordings over the air, or on any business for such public performance of sound recordings.
United States · United States Congress · 12 February 2025
United States-Israel Defense Partnership Act of 2025 This bill requires or authorizes certain actions to increase defense-related cooperation between the United States and Israel. Specifically, the bill requires the Department of Defense (DOD) to establish a cooperative program, with the concurrence of Israel's Ministry of Defense (MOD), to develop and deploy advanced technologies for countering unmanned systems that threaten the United States and Israel; establish in Israel an office of the Defense Innovation Unit (an organization that focuses on rapidly fielding and scaling commercial technology across the U.S. military); and seek to engage Israel's MOD on the ascension of Israel into the national technology and industrial base (currently defined in law as the persons and organizations engaged in research, development, production, integration, services, or information technology activities conducted within the United States, the United Kingdom, Australia, New Zealand, and Canada). The bill authorizes DOD, upon request of Israel's MOD, to jointly conduct research, development, test, and evaluation (RDT&E) of emerging technologies such as artificial intelligence and robotics to meet defense challenges. Additionally, the bill extends the authority for DOD to (1) carry out RDT&E on a joint basis with Israel to establish anti-tunnel and counter unmanned aerial systems capabilities through 2028, and (2) transfer defense articles intended for use as reserve stocks for Israel through January 1, 2029.
United States · United States Congress · 12 February 2025
This bill requires the President to designate Ansarallah, the Iran-backed movement in Yemen also known as the Houthis, as a foreign terrorist organization. The President must also report to Congress a determination as to whether specified foreign persons are officials, agents, or affiliates of Ansarallah.
United States · United States Congress · 12 February 2025
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
![Official portrait of Rep. Crenshaw, Dan [R-TX-2]](https://www.congress.gov/img/member/698a13d0a7af728d4e6c2038_200.jpg)